Article Text

other Versions

Download PDFPDF
Evidence suggests dexamethasone is a better choice than prednisolone for acute asthma attacks in children
  1. Ian P Sinha1,2
  1. 1Respiratory Unit, Alder Hey Children's NHS Foundation Trust, Liverpool, UK
  2. 2Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK
  1. Correspondence to Dr Ian P Sinha, Alder Hey Children's NHS Foundation Trust, Liverpool L12 2AP, UK; iansinha{at}liv.ac.uk

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

In children with asthma attacks, (1) giving a steroid is better than not giving a steroid; (2) giving a dose of steroid early (preferably within the first hour of arrival) is better than giving it late; and (3) education and empowerment of children and their families is crucial. These points are more important than which oral steroid is used. Notwithstanding this I hope to explain why the evidence backs my opinion that dexamethasone is a better choice than prednisolone for acute asthma in children. In the regional children’s hospital in which I work, we started using dexamethasone for acute asthma in September 2016, as part of a refresh of local guidelines.

The first consideration is effectiveness of the two drugs. The best way to evaluate this is using meta-analysis of clinically relevant outcomes in randomised controlled trials (RCTs). When developing our guidelines we asked parents, nurses, and doctors from general paediatric and emergency medicine backgrounds which outcomes were of most interest. They highlighted that switching to dexamethasone would not be acceptable if it was less effective than prednisolone at preventing admission from the emergency department (ED), or if it carried a higher risk of readmission. We identified one meta-analysis from 2014 in which the pooled results of six RCTs did not show a difference in any efficacy outcome between dexamethasone and prednisolone when given in ED, including the need for admission during the initial ED visit, or relapse of …

View Full Text

Footnotes

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; externally peer reviewed.

Linked Articles

  • Atoms
    Nick Brown